iothalamate-meglumine and Colonic-Neoplasms

iothalamate-meglumine has been researched along with Colonic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for iothalamate-meglumine and Colonic-Neoplasms

ArticleYear
Peritoneal carcinomatosis: preoperative CT with intraperitoneal contrast material.
    Radiology, 1992, Volume: 182, Issue:1

    Thirty-five abdominal computed tomographic (CT) scans of 27 patients with peritoneal metastases from a mucin-producing tumor of the appendix, colon, small bowel, or ovary were retrospectively reviewed. Fifteen scans were obtained of 15 patients after CT with intraperitoneal infusion of contrast material (IP), and 20 scans were obtained of 16 patients with CT without IP. Subsequent exploratory laparotomy revealed that all 27 patients had multi-focal spread of peritoneal metastases. The sensitivity of CTIP and CT without IP for detection of peritoneal metastases at all sites of involvement was 61% and 59%, respectively. For CTIP, the highest sensitivity was in the right subphrenic space (88%), splenic hilum (86%), and left subphrenic space (83%). For CT without IP, the highest sensitivity was noted in the splenic hilum (100%), left subphrenic space (75%), and left paracolic gutter (75%). CTIP and CT without IP had low sensitivity for detection of disease in the greater omentum (50% each) and small-bowel mesentery (38% and 59%, respectively), two areas that had the highest frequency of metastases.

    Topics: Appendiceal Neoplasms; Colonic Neoplasms; Female; Humans; Infusions, Parenteral; Iothalamate Meglumine; Male; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Preoperative Care; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed

1992